Tysabri 300mg concentrate for solution for infusion
*Company:
Biogen Idec (Ireland) LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Physician Information and Management Guidelines for Patients with Multiple Sclerosis recieving TYSABRI therapy
Risk Minimisation Materials
(Click to Download) Treatment Initiation Form
Risk Minimisation Materials
(Click to Download) Treatment Continuation Form
Risk Minimisation Materials
(Click to Download) Treatment Discontinuation Form
Risk Minimisation Materials
(Click to Download) HCP Informational Supplement
Risk Minimisation Materials
(Click to Download) Outside Clinical Setting Administration Checklist
Risk Minimisation Materials
Biogen Idec (Ireland) Ltd
Address:
United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, IrelandMedical Information E-mail:
MedInfoUKI@biogen.comMedical Information Direct Line:
1800 812 719